EpiCept to Present at the Cowen and Company 31st Annual Healthcare Conference
March 03, 2011 17:31 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the Cowen and Company 31st Annual Healthcare
Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and...
EpiCept Identifies Ceplene® Survival Benefit in Key AML Subgroup
March 03, 2011 00:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Identifies Ceplene® Survival Benefit in Key AML Subgroup
Files New Patent Applications for Ceplene® in AML of Monocyte Origin
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept Reports Fourth Quarter and Full Year 2010 Operating and Financial Results
February 24, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Reports Fourth Quarter and Full Year 2010 Operating and
Financial Results
Conference Call to Be Held at 9:00 A.M. Eastern Time Today
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept to Present at The Wall Street Analyst Forum 22nd Annual Investor Conference
February 23, 2011 18:00 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at The Wall Street Analyst Forum 22nd Annual Investor
Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq...
EpiCept to Report Fourth Quarter and Full Year 2010 Operating and Financial Results on February 24, 2011
February 18, 2011 17:30 ET
|
Immune Pharmaceuticals Inc
EpiCept to Report Fourth Quarter and Full Year 2010 Operating and
Financial Results on February 24, 2011
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept to Present at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference on February 17
February 16, 2011 16:08 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the Lippert/Heilshorn Life Sciences & MedTech
Virtual Conference on February 17
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept to Present at the 13th Annual BIO CEO & Investor Conference
February 09, 2011 17:06 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the 13th Annual BIO CEO & Investor Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX...
EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy
February 07, 2011 00:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients
with Chemotherapy-Induced Peripheral Neuropathy
All Primary Endpoints Met with Statistical Significance
TARRYTOWN,...
EpiCept to Present at Two Upcoming Industry Conferences
January 06, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at Two Upcoming Industry Conferences
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
EpiCept Regains Compliance With Nasdaq's Minimum Market Value of Listed Securities
January 03, 2011 00:05 ET
|
Immune Pharmaceuticals Inc
EpiCept Regains Compliance With Nasdaq's Minimum Market Value of Listed
Securities
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq...